Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology
This study is the first to suggest TB in pretreatment biopsy specimens as a reliable morphologic prognosticator in cervical cancer. TME features may enhance precision oncology by offering insights into the individual tumour biology. The fact that these morphologic features are available from routine H&E slides, reserving immunohistochemistry or molecular analysis for indeterminate cases, is of particular value in low-resource settings where the burden of cervical cancer is most significant.
Authors
- Yeon‐Sil Kim
- Sung Hak Lee (ORCID: https://orcid.org/0000-0003-1020-5838)
- C. J. Kim
- Y. Lee
- N Bizzarri
- Sea‐Won Lee
- Kwangil Yim
- Tiara Bunga Mayang Permata
- Jin‐Hwi Kim
- Songmi Jeong
Institutions
- Agostino Gemelli University Polyclinic (IT)
- St. Mary's Hospital (US)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (ID)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Histopathology
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1111/his.70053
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00